AUS
NZ
UK
CA
USA
IND
Healthcare
Pathkey.AI Ltd ASX 200 Today Expands Quoted Share Base Through ASX Filing
February 04, 2026 03:14 PM AEDT| By SamPathkey.AI Ltd progressed an application to quote additional ordinary fully paid shares on the ASX following shareholder approval, aligning issued capital with exchange records.
PathKey.AI’s ASX Move Signals a New Chapter for Australian Tech
February 04, 2026 03:14 PM AEDT| By SamPathKey.AI’s ASX quotation step highlights how Australian artificial intelligence companies are strengthening market visibility and aligning innovation with transparent exchange participation.
Telix Pharmaceuticals Faces Market Test Amid Regulatory Shifts
February 04, 2026 02:59 AM AEDT| By SamA user-friendly overview of Telix Pharmaceuticals’ regulatory journey, market sentiment, and healthcare sector positioning, with insights into how wider ASX trends and investor focus intersect with long-term research and development strategies.
Rhythm Biosciences Advances ColoSTAT With Global Manufacturing Support
February 03, 2026 10:53 PM AEDT| By SamRhythm Biosciences expands its ColoSTAT commercial journey through a manufacturing partnership that supports quality standards, global logistics, and market visibility within the broader ASX stock market landscape.
Ansell ASX 200 Healthcare Operations Reflect Product Portfolio Expansion
February 03, 2026 06:06 PM AEDT| By SamAnsell remains positioned within Australia’s listed healthcare sector as manufacturing activity and product portfolio updates continue under regulated market frameworks.
Visionflex and ASX All Ordinaries Context Around Additional Share Quotation
February 03, 2026 05:09 PM AEDT| By SamVisionflex advances an ASX quotation request for additional ordinary shares, highlighting ongoing corporate structuring within Australia’s digital healthcare and telehealth sector.
Telix Pharmaceuticals within ASX 200 Draws Focus as Market Reacts to RBA Move
February 03, 2026 04:23 PM AEDT| By SamTelix Pharmaceuticals remains a notable healthcare presence within major Australian indices as governance updates and monetary policy direction shape broader market structure.
Doctor Care Anywhere (ASX:DOC) Moves With All Ordinaries Index
February 03, 2026 04:16 PM AEDT| By SamAn overview of Doctor Care Anywhere Group PLC covering digital healthcare operations, operating balance progress, and sector context, with reference to All Ordinaries and broader Australian equity benchmarks.
Healthcare diagnostics activity framed within the All Ordinaries
February 03, 2026 12:01 PM AEDT| By SamHealthcare diagnostics operations outlined within the All Ordinaries, detailing manufacturing coordination and regulated participation in the Australian listed market.
All Ordinaries context shapes Doctor Care Anywhere healthcare operations
February 03, 2026 11:22 AM AEDT| By SamHealthcare sector content outlining digital service delivery by Doctor Care Anywhere within the All Ordinaries and the regulated Australian listed market framework.
All Ordinaries context frames Australian biotech neurological work
February 02, 2026 06:56 PM AEDT| By SamBiotechnology sector content outlining neurological research activity within the All Ordinaries and the structured framework of the Australian listed healthcare market.
All Ordinaries context surrounds Antares Metals Western Australia entry
February 02, 2026 02:11 PM AEDT| By SamMaterials sector content describing Antares Gold’s Western Australia asset participation within the All Ordinaries and the regulated Australian listed market framework.
Prescient Therapeutics Within All Ordinaries Biotechnology Landscape
January 30, 2026 04:42 PM AEDT| By SamPrescient Therapeutics advanced clinical biotechnology activity through European regulatory authorisations while maintaining participation within the All Ordinaries healthcare sector.
ASX 200 Healthcare Framework Reflects Ansell Operational Presence
January 30, 2026 03:17 PM AEDT| By SamAnsell maintained healthcare manufacturing and safety equipment operations while participating within the ASX 200 and All Ordinaries market framework.
Oneview Healthcare Outlook on the ASX Market: A Long-Term Growth Narrative
January 30, 2026 12:40 PM AEDT| By SamOneview Healthcare reflects the growing role of digital platforms in healthcare, highlighting long-term relevance within Australia’s evolving equity market landscape.
AdAlta’s Capital Expansion Move: What It Signals for Market Watchers
January 30, 2026 12:11 PM AEDT| By SamAdAlta’s capital update highlights strategic planning within Australia’s evolving equity landscape, reflecting broader trends in innovation-driven market participation.
AdAlta’s ASX Update Sparks Fresh Market Attention in Australia
January 30, 2026 12:07 PM AEDT| By SamAdAlta’s market update reflects strategic capital positioning, reinforcing its presence within Australia’s evolving healthcare and equity landscape.
Mesoblast (ASX:MSB) Expands Ryoncil Adoption and Adult Trials
January 29, 2026 06:20 PM AEDT| By SamMesoblast (ASX:MSB) expands Ryoncil adoption in pediatric and adult patients, advancing cell therapies for severe conditions and chronic pain, highlighting growth in innovative healthcare solutions.
Lumos Diagnostics (ASX:LDX) Accelerates FebriDx Rollout with US Growth Surge
January 29, 2026 05:53 PM AEDT| By SamLumos Diagnostics expands FebriDx adoption in the US and globally, advancing regulatory approvals, Medicare reimbursement, and paediatric studies while strengthening commercial execution.
Cell Therapy Development Update Places Arovella Therapeutics in All Ordinaries
January 29, 2026 05:31 PM AEDT| By SamArovella Therapeutics achieved regulatory clearance for its ALA one zero one program, supporting progression toward initial clinical evaluation and reinforcing its presence within the All Ordinaries.
Advertise your brand on Kalkine Media